Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer (stage I to IV) through a tissue or cell sample, have not yet had any first-line treatment, and are planned to receive chemotherapy before surgery (with or without radiation therapy)
- People whose cancer can be measured by ultrasound or MRI, with that scan done within 28 days before starting treatment
- People who are generally able to carry out daily activities with little to no limitation, as measured by a standard medical scale called the ECOG scale (score of 0 or 1) (confirm with trial site)
- People with a life expectancy of at least 6 months
- People whose blood test results, taken within 7 days before starting treatment, show that the bone marrow, liver, and kidneys are functioning well enough to meet the trial's required levels (confirm with trial site for specific values)
- People who are able to understand and are willing to sign a written consent form before any trial-related procedures take place
Who may not be able to join:
- People who have had chemotherapy, radiation therapy, or major surgery within 4 weeks before joining the trial, or who have not yet recovered from side effects of earlier treatments
- People who are currently taking part in another clinical trial involving an experimental treatment
- People who have cancer that has spread to the brain
- People who have a history of allergic reactions to medicines with a similar chemical or biological makeup to the trial drug (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gregory J. Czarnota, Ph.D. M.D., Sunnybrook Health Sciences Centre
Phone: 416-480-5329
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The primary Outcome will be correlate changes in ultrasound backscatter parameters obtained throughout the course of treatment with pathological complete, partial, or complete and partial response.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.